Therapeutics Novartis Venture Fund and Columbus Venture Partners have led a €37.5m series-A round for biotechnology group Vivet Therapeutics.
The GP said it will pursue a buy-and-build strategy in the life science IT services sector
Dominic Schmidt is based in the UK, while Satish Jindal and Katrine Bosley join in the US
Five Arrows has owned a majority stake in the France-based low-cost pharmacy chain since 2016
Hg acquired the software platform for care providers in 2018 from ECM Equity Capital Management